Activated T cell therapy for advanced melanoma developed

T cells from patients with melanoma can trigger a protective immune response against the disease, according to a new study. These new findings demonstrate that T cells derived from lymph nodes of patients with melanoma can be expanded in number and activated in the laboratory for intravenous administration in the treatment of patients.

from Today's Healthcare News -- ScienceDaily http://ift.tt/1NLS0cV